(R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-methanol, 95.0%, 500g

3-Acetamido-4-methyl-2-nitrobenzoic acid, 95.0%, 10g

3-Phenoxybenzyl chloride, 98.0%, 10g

6-Bromo-1,2,4-triazin-3-amine, 95.0%, 250mg

4-Oxo-6-(thiophen-2-yl)-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile, 98%, 1g

8-Fluoro-1,2,3,4-tetrahydroquinoline hydrochloride, 95%, 50mg

5-Boc-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine, 97.0%, 25g

METHYL 4-(METHYLAMINO)BUTANOATE HCL, 95.0%, 25g

Sodium 2,6-Dinitro-4-(trifluoromethyl)benzenesulfonate>95.0%(T)25g

Test sieve Ø 200 mm, 0.106 mm, 1 Piece(s)

2-(Pyrazin-2-yl)ethanamine, 95.0%, 1g

Trial kit Spectra/Por® Biotech CE, 100000 dalton(s), 1 Piece(s)

2-(3-Butyn-1-yloxy)acetic acid, 1g